Miroculus
AcquiredSan Francisco, United States · Founded 2014 · $47.3M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- miroculus.com
- Total Funding
- $47.3M
- Last Round
- $45.0M Series BFeb 2021
- Rounds
- 2
- Acquisition Date
- Mar 2023
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Miroculus was a San Francisco-based biotechnology company that developed hands-off, sample-to-answer automation solutions for molecular testing, specializing in next-generation sequencing (NGS) sample and library preparation. Founded in 2014, the company built the MIRO CANVAS, a compact digital microfluidics platform that fully automates complex NGS protocols and reduces hands-on time to just 15 minutes. In March 2023, Miroculus was acquired by INTEGRA Biosciences to accelerate genomics discovery workflows.
Summary
Miroculus is a Biotech company based in San Francisco, United States, founded in 2014. It has raised $47.3M in total across 2 rounds, most recently a $45.0M Series B round in Feb 2021. Investors include Cota Capital and Section 32.
Funding & Exit History
Mar 2023
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/miroculus"><img src="https://indexed.vc/api/badge/company/miroculus" alt="Miroculus on Indexed.vc" width="260" height="76" /></a>